Zhang Yanfang, Li Mengnan, Liu Sikai, Liu Bo, Wu Xiaobo, Han Yongtai, Wu Tao
Department of Bone Disease, Third Hospital of Hebei Medical University, No. 139 Ziqiang Road, Qiaoxi District, Shijiazhuang 050051, Hebei Province, China.
Heliyon. 2022 Dec 9;8(12):e12212. doi: 10.1016/j.heliyon.2022.e12212. eCollection 2022 Dec.
Our research mainly evaluates the clinical efficacy of two surgical methods in the treatment of osteonecrosis of the femoral head (ONFH) at ARCO stage II, aiming to provide optimal hip-preserving treatment of ONFH.
From October 2018 to September 2020, 48 patients (59 hips) met the inclusion criteria and randomized. 24 cases (29 hips) in experimental group were treated with minimally-invasive fibular supporting of T-type; 24 cases (30 hips) in control group were treated with traditional bloody iliac flap metastasis. We will compare some intraoperative and postoperative conditions.
The operation time in experimental group was 37 (6) minutes, in control group was 130 (21.75) minutes; the length of surgical incision in two groups was 3.7 (0.7) cm and 12.85 (2.68) cm. The intraoperative blood loss in two groups was 69 (21) ml and 363 (87) ml; the postoperative VAS score of the experimental group on day 1, day 3, day 7 after surgery was 5.5 (2), 3.5 (1), 0 (1); the control group was 6 (1.75), 4 (1), 3 (1). The data differences between above groups have statistically significant. The follow-up time of two groups was (33.86 ± 5.66) months and (35.67 ± 4.69) months. The bone graft healing time in two groups was (14.21 ± 1.93) months and (13.83 ± 2.34) months. The Harris hip scores of two groups at the last follow-up were 90 (7.5) and 86.5 (8.5). The survival rates of two groups were 79.31% (23/29) and 76.67% (23/30). The difference was no statistically significant in above groups (P > 0.05).
The two different bone graft implantation showed satisfactory early outcomes. Compared to the control group, the experimental group has the advantages of lesser pain, lesser blood loss, lesser trauma and shorter operation time. It may be a choice as bone graft for the treatment of ONFH at early stage.
本研究主要评估两种手术方法治疗ARCO II期股骨头坏死(ONFH)的临床疗效,旨在为ONFH提供最佳的保髋治疗方案。
2018年10月至2020年9月,48例(59髋)患者符合纳入标准并被随机分组。试验组24例(29髋)采用微创T型腓骨支撑术治疗;对照组24例(30髋)采用传统带血髂骨瓣转移术治疗。我们将比较一些术中及术后情况。
试验组手术时间为37(6)分钟,对照组为130(21.75)分钟;两组手术切口长度分别为3.7(0.7)cm和12.85(2.68)cm。两组术中失血量分别为69(21)ml和363(87)ml;试验组术后第1天、第3天、第7天的视觉模拟评分(VAS)分别为5.5(2)、3.5(1)、0(1);对照组分别为6(1.75)、4(1)、3(1)。上述组间数据差异具有统计学意义。两组随访时间分别为(33.86±5.66)个月和(35.67±4.69)个月。两组骨移植愈合时间分别为(14.21±1.93)个月和(13.83±2.34)个月。两组末次随访时的Harris髋关节评分分别为90(7.5)和86.5(8.5)。两组生存率分别为79.31%(23/29)和76.67%(23/30)。上述组间差异无统计学意义(P>0.05)。
两种不同的骨移植植入术早期疗效均令人满意。与对照组相比,试验组具有疼痛轻、失血少、创伤小、手术时间短等优点。它可能是早期治疗ONFH的一种骨移植选择。